Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death

By W. Ray, C. Chung, K. Murray, K. Hall, M. Stein. New England Journal of Medicine, 2009

1,149 citations recorded by the source corpus.

Background Users of typical antipsychotics have increased risk of serious ventricular arrhythmias and sudden cardiac death. However, less is known regarding the cardiac safety of the atypical antipsychotic drugs, which have largely replaced the older agents in clinical practice. Methods We calculated the adjusted incidence of sudden cardiac death among current users of antipsychotics in a retrospective cohort of Tennessee Medicaid enrollees. The primary analysis included 44,218 and 46,089 baseline users of single typical and atypical drugs, respectively, and 186,600 matched nonuser controls. To assess residual confounding related to antipsychotic indication, we performed a secondary analysis of antipsychotic users with no baseline diagnosis of schizophrenia or related psychoses, propensity-score matched with nonusers. Results Current users of both typical and atypical antipsychotics had greater rates of sudden cardiac death than did nonusers of any antipsychotic, with adjusted incidence-rate ratios (IRRs) of 2.00 (95% CI, 1.69–2.35) and 2.27 (1.89–2.73), respectively. Former antipsychotic users had no significantly increased risk (IRR = 1.13 [0.98–1.30]). For both classes of drugs, the risk for current users increased significantly with dose. For typical antipsychotics the IRRs increased from 1.31 (0.97–1.77) for low doses to 2.42 (1.91–3.06) for high doses (p<.001). For atypical agents the IRRs increased from 1.59 (1.03–2.46) for low doses to 2.86 (2.25–3.65) for high doses (p=.015). The IRR for atypical vs typical antipsychotics was 1.14 (.93–1.39). Similar findings were present in the propensity-score matched cohort. Conclusion Current users of both typical and atypical antipsychotics had a similar, dose-related increased risk of sudden cardiac death.

Subfields: Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/af744af99f2a860d1b0e9c39718fa6d610ace870

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

In Psychiatry and Mental health

Citations in the corpus

Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study. (2009, background): “25,26 Researchers have looked beyond SRS databases and phar-mocoepidemiology databases to search for safety signals and have started to use EHRs for ADE detection.”
The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers (2013, neutral): “48 49 Finally, inequalities in access to, and use of, healthcare are well documented.”
Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) (2009, background): “26 fold increased rate of sudden cardiac death in current users of typical and atypical antipsychotics [110].”
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders (2015, background): “Australian & New Zealand Journal of Psychiatry, 49(12) the risk of cardiovascular accidents in patients with dementia (Ray et al., 2009).”
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs (2012, background): “a large pharmacoepidemiological study in patients receiving antipsychotic monotherapy (44,218 users of first-generation drugs, 46,089 users of second-generation and 186,600 nonusers matched for cardiovascular disease risk based on patient data on file), showed a similar, dose-dependent increase in t”
hERG K(+) channels: structure, function, and clinical significance. (2012, background): “(515) looking at the incidence of sudden cardiac death (SCD) in patients taking antipsychotic medications.”
Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder (2015, background): “8, depending on the type of antipsychotic and restrictiveness of the SCD definition (11,131,135,136).”